Spinal biologics market to hit $2.3B by 2027: 5 notes

Biologics

The global spinal biologics industry is projected to reach $2.3 billion by 2027, growing at a compound annual growth rate of 2.8 percent, according to ReportLinker.com.

Five notes:

1. The spinal biologics market is estimated at $1.9 billion for 2020, with the U.S. accounting for $504 million.

2. The revised report reduced previously communicated projections due to the economic implications caused by the COVID-19 pandemic.

3. The bone graft market segment is expected to rise at a CAGR of 2.6 percent and reach $1.4 billion by 2027.

4. China is anticipated to see a 5.2 percent CAGR in the spinal biologics market, hitting $457.7 million by the end of the forecast period.

5. Japan, Canada and Germany are highlighted as noteworthy market competitors.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers